<DOC>
	<DOCNO>NCT00927342</DOCNO>
	<brief_summary>Following lung surgery air may continue leak surface lung . Chest drain place allow air remove safely prevent lung collapse . Drains need remain air leak lung cease . Air continue leak result longer chest drainage time cause increased discomfort immobility patient . These patient risk secondary complication infection . Longer hospital stay increase cost ensue . A randomised control trial ( RCT ) conduct The Royal Brompton Hospital show clear benefit management difficult air leak use BioGlue . BioGlue surgical sealant apply surface lung time surgery . BioGlue bovine origin . Concerns exist regard potential risk transmission blood borne diseases bovine derive medical product . Should surgical adhesive without potential risk prove effective BioGlue use could commend . The Vivostat System medical system derive sealant patient 's blood . A small study show may also benefit management difficult air leak . The principal aim RCT compare duration air leak , length chest drainage hospital stay associate BioGlue Vivostat .</brief_summary>
	<brief_title>BioGlue Vivostat Control Air Leak Thoracic Surgery</brief_title>
	<detailed_description />
	<criteria>Adults ( 18 year ) Males females Patients undergo thoracic surgical procedure likely result alveolar air leak . Written inform consent Age le 18 year Pregnancy Breast feed Previous treatment BioGlue Vivostat Inability give inform consent Pneumonectomy Empyema Grade 0 air leak</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Air leak</keyword>
	<keyword>Thoracic Surgery</keyword>
	<keyword>Sealants</keyword>
</DOC>